TAMs have been proven to influence CD8 T cell-mediated tumor suppression to inhibit tumor cell invasion, metastasis, and desmoplasia through PI3Kγ in PDAC [33], which presents a novel therapeutic target for treating PDAC. This evidence concerns the gene CD8A and neoplasm.